Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
- PMID: 24243558
- DOI: 10.1002/ana.24066
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
Abstract
Objective: Mounting evidence suggests that α-synuclein, a major protein component of Lewy bodies (LB), may be responsible for initiating and spreading the pathological process in Parkinson disease (PD). Supporting this concept, intracerebral inoculation of synthetic recombinant α-synuclein fibrils can trigger α-synuclein pathology in mice. However, it remains uncertain whether the pathogenic effects of recombinant synthetic α-synuclein may apply to PD-linked pathological α-synuclein and occur in species closer to humans.
Methods: Nigral LB-enriched fractions containing pathological α-synuclein were purified from postmortem PD brains by sucrose gradient fractionation and subsequently inoculated into the substantia nigra or striatum of wild-type mice and macaque monkeys. Control animals received non-LB fractions containing soluble α-synuclein derived from the same nigral PD tissue.
Results: In both mice and monkeys, intranigral or intrastriatal inoculations of PD-derived LB extracts resulted in progressive nigrostriatal neurodegeneration starting at striatal dopaminergic terminals. No neurodegeneration was observed in animals receiving non-LB fractions from the same patients. In LB-injected animals, exogenous human α-synuclein was quickly internalized within host neurons and triggered the pathological conversion of endogenous α-synuclein. At the onset of LB-induced degeneration, host pathological α-synuclein diffusely accumulated within nigral neurons and anatomically interconnected regions, both anterogradely and retrogradely. LB-induced pathogenic effects required both human α-synuclein present in LB extracts and host expression of α-synuclein.
Interpretation: α-Synuclein species contained in PD-derived LB are pathogenic and have the capacity to initiate a PD-like pathological process, including intracellular and presynaptic accumulations of pathological α-synuclein in different brain areas and slowly progressive axon-initiated dopaminergic nigrostriatal neurodegeneration.
© 2014 Child Neurology Society/American Neurological Association.
Comment in
-
The prion hypothesis of Parkinson's disease: this hot topic just got hotter.Mov Disord. 2014 Jul;29(8):988. doi: 10.1002/mds.25918. Epub 2014 May 27. Mov Disord. 2014. PMID: 24867814 No abstract available.
Similar articles
-
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.Neurobiol Dis. 2015 Oct;82:185-199. doi: 10.1016/j.nbd.2015.06.003. Epub 2015 Jun 17. Neurobiol Dis. 2015. PMID: 26093169 Free PMC article.
-
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.Acta Neuropathol Commun. 2018 Feb 8;6(1):8. doi: 10.1186/s40478-018-0509-1. Acta Neuropathol Commun. 2018. PMID: 29422109 Free PMC article.
-
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.J Neuroinflammation. 2018 May 1;15(1):129. doi: 10.1186/s12974-018-1171-z. J Neuroinflammation. 2018. PMID: 29716614 Free PMC article.
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
-
Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.Crit Rev Toxicol. 2012 Aug;42(7):613-32. doi: 10.3109/10408444.2012.680431. Epub 2012 May 11. Crit Rev Toxicol. 2012. PMID: 22574684 Review.
Cited by
-
Alpha-synuclein biology in Lewy body diseases.Alzheimers Res Ther. 2014 Oct 27;6(5):73. doi: 10.1186/s13195-014-0073-2. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25580161 Free PMC article. Review.
-
α-Synuclein: Experimental Pathology.Cold Spring Harb Perspect Med. 2016 Sep 1;6(9):a024273. doi: 10.1101/cshperspect.a024273. Cold Spring Harb Perspect Med. 2016. PMID: 27481772 Free PMC article. Review.
-
Neurons and Glia Interplay in α-Synucleinopathies.Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994. Int J Mol Sci. 2021. PMID: 34066733 Free PMC article. Review.
-
Dysregulation of autophagy and mitochondrial function in Parkinson's disease.Transl Neurodegener. 2016 Oct 31;5:19. doi: 10.1186/s40035-016-0065-1. eCollection 2016. Transl Neurodegener. 2016. PMID: 27822367 Free PMC article. Review.
-
Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.Int J Mol Sci. 2022 Nov 25;23(23):14753. doi: 10.3390/ijms232314753. Int J Mol Sci. 2022. PMID: 36499080 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical